Picture of SpringWorks Therapeutics logo

SWTX — SpringWorks Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral

SpringWorks rises after report Germany's Merck has made nearly $3.5 billion deal

** Shares of drugmaker SpringWorks Therapeutics SWTX.O rise 8.2% to $44.59

** Germany's Merck KGaA MRCG.DE is nearing a roughly $3.5 billion deal for SWTX, the Wall Street Journal reports

** Both companies have agreed on a price close to $47 per share, report says

** Up to last close, SWTX up 14% YTD

 (Reporting by Juby Babu in Mexico City)

 ((Juby.Babu@thomsonreuters.com;))

Recent news on SpringWorks Therapeutics

See all news